Kerr Douglas's Insider Trades & SAST Disclosures
Kerr Douglas's most recent trade in Generation Bio Co was a trade of 5,021 Restricted Stock Units done . Disclosure was reported to the exchange on Jan. 29, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kerr Douglas.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Generation Bio Co | Kerr Douglas | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 5,021 | 0 | - | - | Restricted Stock Units | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 5,021 | 387,104 | - | - | Common Stock | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.90 per share. | 29 Jan 2024 | 1,476 | 385,628 | - | 1.9 | 2,804 | Common Stock |
| Generation Bio Co | Kerr Douglas | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2024 | 7,437 | 380,286 | - | - | Common Stock | |
| Generation Bio Co | Kerr Douglas | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2024 | 7,437 | 7,437 | - | - | Restricted Stock Units | |
| Generation Bio Co | Kerr Douglas | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2024 | 6,694 | 20,081 | - | - | Restricted Stock Units | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2024 | 6,694 | 384,403 | - | - | Common Stock | |
| Generation Bio Co | Kerr Douglas | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. | 15 Jan 2024 | 2,577 | 377,709 | - | 1.9 | 4,922 | Common Stock |
| Generation Bio Co | Kerr Douglas | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. | 15 Jan 2024 | 2,320 | 382,083 | - | 1.9 | 4,431 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2023 | 7,437 | 367,333 | - | - | Common Stock | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2023 | 7,437 | 14,874 | - | - | Restricted Stock Units | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. | 15 Jul 2023 | 2,183 | 365,150 | - | 5.1 | 11,090 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2023 | 7,437 | 358,963 | - | - | Common Stock | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2023 | 7,437 | 22,311 | - | - | Restricted Stock Units | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.50 per share. | 15 Apr 2023 | 2,183 | 356,780 | - | 4.5 | 9,824 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 53,550 | 53,550 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 26,775 | 26,775 | - | - | Restricted Stock Units | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2023 | 7,438 | 29,748 | - | - | Restricted Stock Units | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2023 | 7,438 | 354,104 | - | - | Common Stock | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.10 per share. | 15 Jan 2023 | 2,578 | 351,526 | - | 5.1 | 13,148 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2022 | 7,438 | 37,186 | - | - | Restricted Stock Units | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2022 | 7,438 | 346,985 | - | - | Common Stock | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.61 per share. | 15 Oct 2022 | 2,184 | 344,801 | - | 5.6 | 12,252 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 14,876 | 343,914 | - | - | Common Stock | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 14,876 | 44,624 | - | - | Restricted Stock Units | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. | 15 Jul 2022 | 4,367 | 339,547 | - | 7.2 | 31,355 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2022 | 119,000 | 119,000 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2022 | 59,500 | 59,500 | - | - | Restricted Stock Units | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2021 | 3,518 | 38,699 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.16 per share. | 08 Jul 2021 | 3,518 | 330,076 | - | 5.2 | 18,153 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 25.39 per share. | 08 Jul 2021 | 1,889 | 326,558 | - | 25.4 | 47,962 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 24.99 per share. | 08 Jul 2021 | 1,629 | 328,447 | - | 25.0 | 40,709 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 14,072 | 42,217 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.16 per share. | 05 Apr 2021 | 14,072 | 340,630 | - | 5.2 | 72,612 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 29.91 per share. | 05 Apr 2021 | 10,751 | 329,879 | - | 29.9 | 321,562 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.68 per share. | 05 Apr 2021 | 3,321 | 326,558 | - | 30.7 | 101,888 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. | 05 Mar 2021 | 11,267 | 337,825 | - | 4.6 | 51,716 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2021 | 11,267 | 89,959 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.87 per share. | 05 Mar 2021 | 4,315 | 328,333 | - | 31.9 | 137,519 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 29.68 per share. | 05 Mar 2021 | 2,677 | 335,148 | - | 29.7 | 79,453 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.92 per share. | 05 Mar 2021 | 2,500 | 332,648 | - | 30.9 | 77,300 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 32.97 per share. | 05 Mar 2021 | 775 | 327,558 | - | 33.0 | 25,552 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 34.77 per share. | 05 Mar 2021 | 500 | 326,658 | - | 34.8 | 17,385 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 33.75 per share. | 05 Mar 2021 | 400 | 327,158 | - | 33.8 | 13,500 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 35.58 per share. | 05 Mar 2021 | 100 | 326,558 | - | 35.6 | 3,558 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2021 | 11,267 | 101,226 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. | 02 Feb 2021 | 11,267 | 337,825 | - | 4.6 | 51,716 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 33.01 per share. | 02 Feb 2021 | 7,500 | 330,325 | - | 33.0 | 247,575 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 34.08 per share. | 02 Feb 2021 | 3,767 | 326,558 | - | 34.1 | 128,379 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 73,500 | 73,500 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2021 | 11,267 | 112,493 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. | 11 Jan 2021 | 11,267 | 337,825 | - | 4.6 | 51,716 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 27.17 per share. | 11 Jan 2021 | 6,246 | 331,579 | - | 27.2 | 169,704 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 28.05 per share. | 11 Jan 2021 | 4,721 | 326,858 | - | 28.0 | 132,424 | Common Stock |
| Generation Bio Co | Douglas Kerr | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 28.80 per share. | 11 Jan 2021 | 300 | 326,558 | - | 28.8 | 8,640 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges